Tag Archives: ScyTek Laboratories

March 2016—ScyTek Laboratories announced the availability of its Multiplex TTF-1 and Cytokeratin 5 Cocktail. This multiplex cocktail of TTF-1 and cytokeratin 5 produces two-color, high-contrast staining for differentiating primary adenocarcinoma of the lung from metastatic carcinomas of the breast and malignant mesothelioma. This cocktail can increase sensitivity and diagnostic utility in differential diagnosis of the tumor.

February 2016—ScyTek Laboratories announced the availability of Pan Melanoma Cocktail antibody. This cocktail includes Tyrosinase, MART-1, and HMB45 clones.